Usefulness of a titration algorithm for de novo users of sacubitril/valsartan in a tertiary centre heart failure clinic.
CONCLUSIONS: This algorithm is a safe and easy-to-use tool in daily clinical practice for the introduction and titration of sacubitril/valsartan. Almost half of the patients reached the maximal dose, with a tolerability profile in line with the original study.
PMID: 30152839 [PubMed - as supplied by publisher]
Source: Cardiovascular Journal of Africa - Category: Cardiology Authors: Laflamme É, Vachon A, Gilbert S, Boisvert J, Leclerc V, Bernier M, Voisine P, Sénéchal M, Bergeron S Tags: Cardiovasc J Afr Source Type: research
More News: African Health | Cardiology | Cardiovascular | Diovan | Enalapril | Furosemide | Heart | Heart Failure | Potassium | Study